Thrombosis Update

In a recent @thrombosis-update.bsky.social article, the authors show that the Pathfast D-dimer assay is a rapid POC test for determination of D-dimer with good analytical performance.

Read more here:

sciencedirect.com/science/arti...

@lucynortcd.bsky.social #TruJournal

Primary antiphospholipid syndrome and severe mental illness: preliminary results of a long-term case-control study Lupus anticoagulant, multiple or high-titer antiphospholipid antibodies identify patients at high risk of thrombosis and obstetric complications. We a…

Full text link

www.sciencedirect.com/science/arti...

New article in @thrombosis-update.bsky.social

Researchers suggest that patients with multiple or high-titer antiphospholipid antibodies face a seven to 21-fold increased risk of severe mental illness. #APS #TruUpdate

@lucynortcd.bsky.social

New article in @thrombosis-update.bsky.social

"A scoping review protocol on active drug monitoring of direct oral anticoagulants on vulnerable patient groups to detect potential adverse risks"

Read more: here:https://www.sciencedirect.com/science/article/pii/S2666572725000264

A new study in @thrombosis-update.bsky.social reveals that #VTE -related deaths are over three times higher in LA County jails than in the general population. #HealthEquity #PublicHealth #Incarceration

Read more here:
www.sciencedirect.com/science/arti...

@lucynortcd.bsky.social #TruJournal

New article in @thrombosis-update.bsky.social 👇
Findings from a phase 2 trial show that Auxora™ may help patients with severe #COVID19 by reducing D-dimer levels.
@lucynortcd.bsky.social #TruJournal

Read more here:
www.sciencedirect.com/science/arti...

Exploring experiences of patients attending an outpatient thrombosis service in Canada There is limited information on patients' experiences that influence their satisfaction and perception of the quality of care received at comprehensiv…

A new study in #ThrombosisUpdate reveals what patients value in thrombosis care!
Clear info & respectful relationships are key to satisfaction, but virtual options and affordable medication are areas for improvement.
@lucynortcd.bsky.social
Read more here:
www.sciencedirect.com/science/arti...

A new study in @thrombosis-update.bsky.social shows that freezing plasma samples doesn't significantly affect #thrombin generation measurements over long-term storage (up to 2 years at -80°C).
@lucynortcd.bsky.social #TruJournal
Read more here:
www.sciencedirect.com/science/arti...

A new multicenter study in @thrombosis-update.bsky.social from Colombia characterizes anticoagulation reversal practices, revealing bleeding as the primary indication and warfarin as the most common anticoagulant.
@lucynortcd.bsky.social #TruJournal
Full text:
www.sciencedirect.com/science/arti...

In this @thrombosis-update.bsky.social article, the authors found that underdosing #DOACs for nonvalvular atrial fibrillation is linked to higher risks of stroke and major bleeding compared to on-label dosing.
Read more here: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal

New study in @thrombosis-update.bsky.social reveals a significant, often underestimated, risk of blood clots in IBD out-patients. They auhtors found 7.6% experienced a thromboembolic event in IBD patients.
Read more here: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal

A new case study in @thrombosis-update.bsky.social
on hereditary antithrombin deficiency (HATD) in pregnancy shows antithrombin clearance increases in the first and third trimesters, peaking around delivery.
Read more here:
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal

Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study To develop a European shared decision support tool (SDST), a Delphi process will be used to reach consensus about aspects relating to the continuation…

www.sciencedirect.com/science/arti...

What goes into deciding about #Antithrombotic therapy for #cancer patients at end of life? 🤔

The #SERENITY project is finding out!

Read more here in @thrombosis-update.bsky.social
www.sciencedirect.com/science/arti...

@lucynortcd.bsky.social #TruJournal

New meta-analysis in @thrombosis-update.bsky.social
on aspirin for infective endocarditis reveals mixed results for preventing embolic events.
Read more here: www.sciencedirect.com/science/arti...

@lucynortcd.bsky.social #TruJournal

National and regional incidence patterns of venous thromboembolism in Finland during 1998-2021 with corresponding mortality trends in 1998-2019 Previous research suggest that venous thromboembolism (VTE) -related mortality have been declining over the recent decades, despite the increasing tre…

Read the full story here:
www.sciencedirect.com/science/arti...

Why is #VTE mortality falling in Finland🇫🇮 despite soaring #PE incidence? 📉
A nationwide registry study in @thrombosis-update.bsky.social reveals key trends, including stable DVT rates & a surge in diagnostic imaging.
Important and🗝️ findings for #VTE epidemiology.
@lucynortcd.bsky.social

Safe #PE treatment for #cancer patients?
Ultrasound-guided thrombolysis #CDT shows promise! New study in @thrombosis-update.bsky.social found similar low bleeding rates in cancer & non-cancer patients.

Read more here:
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal

Don’t miss out! 🚨 Early registration for #ISTH2025 closes April 22! Register now to score the lowest rates and guarantee your spot at the premier event for cutting-edge science, expert insights & unforgettable connections.

Lock in➡️https://www.isth2025.org/

a man is sitting at a table with his hand to his mouth and the word submit written on his face . ALT: a man is sitting at a table with his hand to his mouth and the word submit written on his face .

From molecular mechanisms to clinical breakthroughs,
@thrombosis-update.bsky.social covers it all!

Submit your original research, reviews, or case reports today.
www.sciencedirect.com/journal/thro...

@lucynortcd.bsky.social #TruJournal

Is there a better way to predict pulmonary thromboembolism #PTE mortality? 🤔
New research in @thrombosis-update.bsky.social says RV/LV ratio on #CTPA might be the key.

Find out more:
how:https://www.sciencedirect.com/science/article/pii/S2666572725000069?via%3Dihub

#TruJournal

Critically ill #COVID19 patients on heparin?
New study in @thrombosis-update.bsky.social reveals aPTT & anti-Xa monitoring often clash, impacting bleeding risk. Switching to anti-Xa guidance?
Could mean fewer #Bleeding events.

Read more here:
www.sciencedirect.com/science/arti...

One size doesn't fit all: DOACs for VTE in inherited thrombophilia need tailored approaches.
New findings in @thrombosis-update.bsky.social emphasize patient-centered care.
Read the full text here:
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal

This new study in @thrombosis-update.bsky.social investigates how multimorbidity and its severity, along with specific disease clusters, relate to the risk of #VTE.
@lucynortcd.bsky.social #TruJournal

Read more here at: www.sciencedirect.com/science/arti...

A study in @thrombosis-update.bsky.social the authors found that rosuvastatin did not prevent thrombus formation nor speed up resolution.
#VTE #TruJournal
Read the full article to learn morehttps://www.sciencedirect.com/science/article/pii/S2666572725000033?via%3Dihub
@lucynortcd.bsky.social

@simonnoble.bsky.social

This recent study in @thrombosis-update.bsky.social compared the safety and effectiveness of using a reduced apixaban lead-in vs. full lead-in dosing in #VTE.

Read more here at: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #ThrJournal

The recent @thrombosis-update.bsky.social paper presents an overview of public involvement as a whole and specifically reflects on how it has added value, to an international cancer associated thrombosis #CAT research.
#ThrJournal @lucynortcd.bsky.social

www.sciencedirect.com/science/arti...

Improving management of catheter related thrombosis (CRT) in cancer patients by incorporating real world data. The value of cancer VTE registries

Here is the editorial commentary by @lucynortcd.bsky.social and Dr. Papadakis on the article by Mateo et al. in
@thrombosis-update.bsky.social in which ther authors presented the data from the TESEO registry.

Read more here: www.sciencedirect.com/science/arti...

Tissue factor (F3) gene variants and thrombotic risk among middle-aged and older adults: A population-based cohort study Tissue factor (TF), encoded by the F3 gene, is the main initiator of blood coagulation. The molecular epidemiology of the F3 gene and the relation to …

Tissue factor (TF aka F3) is the main initiator of blood coagulation. In this new @thrombosis-update.bsky.social study, the authors determined the molecular epidemiology and the importance of #F3 variants for incident #VTE

Read more: www.sciencedirect.com/science/arti...

@lucynortcd.bsky.social